Last update :
01/07/2022
Immunosuppressant   Adalimumab  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amgevita Belgium, Chile, France, Germany, Great Britain
Humira Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Iceland, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America, Venezuela
Imraldi Belgium, Great Britain, Spain
Truxeda Austria, Belgium, Denmark, Finland, Germany, Greece, Iceland, Japan, Poland, Sweden
Stability in solutions   Injection   Stability in solutions : Adalimumab     
Container Solvent Concentration Temperature Storage Length of time References
Polypropylen Syringe None 50 mg/ml 23-27°C Light
28 Day
4627
Level of evidence A+
Biosimilar

  Mentions Légales